National Health (Pharmaceutical Benefits) Amendment Regulation 2012 (No. 2)

Link to law: https://www.comlaw.gov.au/Details/F2012L00902

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
National Health (Pharmaceutical Benefits) Amendment Regulation 2012 (No. 2)1
Select Legislative Instrument 2012 No. 56
I, QUENTIN BRYCE, Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulation under the National Health Act 1953.
Dated 19 April 2012
QUENTIN BRYCE
Governor-General
By Her Excellency’s Command
TANYA PLIBERSEK
Minister for Health
1              Name of regulation
                This regulation is the National Health (Pharmaceutical Benefits) Amendment Regulation 2012 (No. 2).
2              Commencement
                This regulation commences on the day after it is registered.
3              Amendment of National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No. 5)
                Schedule 1 amends the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No. 5).
Schedule 1        Amendment
(section 3)
 
[1]           After subregulation 8 (2)
insert
         (3)   If the first reporting period for the relevant brand ends on 31 January 2012, information about sales revenue and adjusted volume for the relevant brand for the first month of the first reporting period is excluded when using the method set out in regulation 37G of the National Health (Pharmaceutical Benefits) Regulations 1960.
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See www.comlaw.gov.au.